Ignite Creation Date:
2024-05-05 @ 5:19 PM
Last Modification Date:
2024-10-26 @ 9:30 AM
Study NCT ID:
NCT00430586
Status:
COMPLETED
Last Update Posted:
2011-08-03
First Post:
2007-02-01
Brief Title:
Finding of Optimal Dose for NT 201 in the Treatment of Glabellar Frown Lines
Sponsor:
Merz Pharmaceuticals GmbH
Organization:
Merz Pharmaceuticals GmbH
Organization Data
Organization:
Merz Pharmaceuticals GmbH
Class:
INDUSTRY
Study ID:
MRZ 60201-05271
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Merz Pharmaceuticals GmbH
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Public Disclosure Manager
Old Organization:
Merz Pharmaceuticals GmbH